The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Oral abstract session focused on Transfusion Medicine and Cellular Therapy Innovation.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Learning Objectives:
List demographic factors that impact anti-COVID-19 antibody levels in convalescent plasma donors.
Describe the qualities of antibody responses in blood donors who either had a prior COVID-19 infection or were vaccinated against COVID-19.
List proteomic markers that improve engraftment potential of fetal liver-derived hematopoietic stem cells.
Discuss steps that can be taken to improve survival of biotinylated red blood cells.
Moderator(s):
Thomas
Gniadek,
MD, PHD,
University of Chicago (NorthShore) Pathology
Dr. Mary
Berg,
MD,
Professor of Clinical Practice, Pathology Medical Director, Transfusion Services,
University of Colorado
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
AM21-46: Oral Abstract Session -- Transfusion Medicine and Cellular Therapy Innovation Evaluation